GRNQ Q1 2024 Earnings Loss Per Share of 004 as Stock Declines Over 5 Lisata Therapeutics LSTA Q3 2025 Earnings EPS Beat Drives Positive Stock Reaction CDP Q1 2026 Earnings EPS Beats Estimates by 201 Shares Gain 148 Hub Group Q3 2025 Earnings EPS Misses Estimates by a Narrow Margin Stock Edges Higher INAB Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Stage Company Advances Pipeline NRT Q2 2025 Earnings Trust Reports EPS of 020 Stock Advances 064